ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Aspirin-Free Strategies in ACS: Is It the Drug or the Stent?

Sunday, February 21, 2021

Submitted by

Source

Source Name: JACC: Cardiovascular Interventions

Author(s)

Michel Zeitouni Paul Guedeney

An editorial that may herald the decrease in aspirinization and the rise of ticagrelor monotherapy in Percutaneous stenting of coronary arteries. There might be a peripheral relevance to the group of our patients undergoing urgent surgical revascularisation after failed PCI: the balance of protecting the angioplasty versus minimising peri and postoperative heamorrhage is yet to be achieved.

Add comment

Log in or register to post comments